Cargando…

A buffered form of creatine does not promote greater changes in muscle creatine content, body composition, or training adaptations than creatine monohydrate

BACKGROUND: Creatine monohydrate (CrM) has been consistently reported to increase muscle creatine content and improve high-intensity exercise capacity. However, a number of different forms of creatine have been purported to be more efficacious than CrM. The purpose of this study was to determine if...

Descripción completa

Detalles Bibliográficos
Autores principales: Jagim, Andrew R, Oliver, Jonathan M, Sanchez, Adam, Galvan, Elfego, Fluckey, James, Riechman, Steven, Greenwood, Michael, Kelly, Katherine, Meininger, Cynthia, Rasmussen, Christopher, Kreider, Richard B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3479057/
https://www.ncbi.nlm.nih.gov/pubmed/22971354
http://dx.doi.org/10.1186/1550-2783-9-43
_version_ 1782247393738096640
author Jagim, Andrew R
Oliver, Jonathan M
Sanchez, Adam
Galvan, Elfego
Fluckey, James
Riechman, Steven
Greenwood, Michael
Kelly, Katherine
Meininger, Cynthia
Rasmussen, Christopher
Kreider, Richard B
author_facet Jagim, Andrew R
Oliver, Jonathan M
Sanchez, Adam
Galvan, Elfego
Fluckey, James
Riechman, Steven
Greenwood, Michael
Kelly, Katherine
Meininger, Cynthia
Rasmussen, Christopher
Kreider, Richard B
author_sort Jagim, Andrew R
collection PubMed
description BACKGROUND: Creatine monohydrate (CrM) has been consistently reported to increase muscle creatine content and improve high-intensity exercise capacity. However, a number of different forms of creatine have been purported to be more efficacious than CrM. The purpose of this study was to determine if a buffered creatine monohydrate (KA) that has been purported to promote greater creatine retention and training adaptations with fewer side effects at lower doses is more efficacious than CrM supplementation in resistance-trained individuals. METHODS: In a double-blind manner, 36 resistance-trained participants (20.2 ± 2 years, 181 ± 7 cm, 82.1 ± 12 kg, and 14.7 ± 5% body fat) were randomly assigned to supplement their diet with CrM (Creapure® AlzChem AG, Trostberg, Germany) at normal loading (4 x 5 g/d for 7-days) and maintenance (5 g/d for 21-days) doses; KA (Kre-Alkalyn®, All American Pharmaceutical, Billings, MT, USA) at manufacturer’s recommended doses (KA-L, 1.5 g/d for 28-days); or, KA with equivalent loading (4 x 5 g/d for 7-days) and maintenance (5 g/d) doses of CrM (KA-H). Participants were asked to maintain their current training programs and record all workouts. Muscle biopsies from the vastus lateralis, fasting blood samples, body weight, DEXA determined body composition, and Wingate Anaerobic Capacity (WAC) tests were performed at 0, 7, and 28-days while 1RM strength tests were performed at 0 and 28-days. Data were analyzed by a repeated measures multivariate analysis of variance (MANOVA) and are presented as mean ± SD changes from baseline after 7 and 28-days, respectively. RESULTS: Muscle free creatine content obtained in a subgroup of 25 participants increased in all groups over time (1.4 ± 20.7 and 11.9 ± 24.0 mmol/kg DW, p = 0.03) after 7 and 28-days, respectively, with no significant differences among groups (KA-L −7.9 ± 22.3, 4.7 ± 27.0; KA-H 1.0 ± 12.8, 9.1 ± 23.2; CrM 11.3 ± 23.9, 22.3 ± 21.0 mmol/kg DW, p = 0.46). However, while no overall group differences were observed (p = 0.14), pairwise comparison between the KA-L and CrM groups revealed that changes in muscle creatine content tended to be greater in the CrM group (KA-L −1.1 ± 4.3, CrM 11.2 ± 4.3 mmol/kg DW, p = 0.053 [mean ± SEM]). Although some significant time effects were observed, no significant group x time interactions (p > 0.05) were observed in changes in body mass, fat free mass, fat mass, percent body fat, or total body water; bench press and leg press 1RM strength; WAC mean power, peak power, or total work; serum blood lipids, markers of catabolism and bone status, and serum electrolyte status; or, whole blood makers of lymphocytes and red cells. Serum creatinine levels increased in all groups (p < 0.001) with higher doses of creatine promoting greater increases in serum creatinine (p = 0.03) but the increases observed (0.1 – 0.2 mg/dl) were well within normal values for active individuals (i.e., <1.28 ± 0.2 mg/dl). Serum LDL was decreased to a greater degree following ingesting loading doses in the CrM group but returned to baseline during the maintenance phase. No side effects were reported. CONCLUSIONS: Neither manufacturers recommended doses of KA (1.5 g/d) or KA with equivalent loading (20 g/d for 7-days) and maintenance doses (5 g/d for 21-days) of CrM promoted greater changes in muscle creatine content, body composition, strength, or anaerobic capacity than CrM (20 g/d for 7-days, 5 g/d for 21-days). There was no evidence that supplementing the diet with a buffered form of creatine resulted in fewer side effects than CrM. These findings do not support claims that consuming a buffered form of creatine is a more efficacious and/or safer form of creatine to consume than creatine monohydrate.
format Online
Article
Text
id pubmed-3479057
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34790572012-10-24 A buffered form of creatine does not promote greater changes in muscle creatine content, body composition, or training adaptations than creatine monohydrate Jagim, Andrew R Oliver, Jonathan M Sanchez, Adam Galvan, Elfego Fluckey, James Riechman, Steven Greenwood, Michael Kelly, Katherine Meininger, Cynthia Rasmussen, Christopher Kreider, Richard B J Int Soc Sports Nutr Research Article BACKGROUND: Creatine monohydrate (CrM) has been consistently reported to increase muscle creatine content and improve high-intensity exercise capacity. However, a number of different forms of creatine have been purported to be more efficacious than CrM. The purpose of this study was to determine if a buffered creatine monohydrate (KA) that has been purported to promote greater creatine retention and training adaptations with fewer side effects at lower doses is more efficacious than CrM supplementation in resistance-trained individuals. METHODS: In a double-blind manner, 36 resistance-trained participants (20.2 ± 2 years, 181 ± 7 cm, 82.1 ± 12 kg, and 14.7 ± 5% body fat) were randomly assigned to supplement their diet with CrM (Creapure® AlzChem AG, Trostberg, Germany) at normal loading (4 x 5 g/d for 7-days) and maintenance (5 g/d for 21-days) doses; KA (Kre-Alkalyn®, All American Pharmaceutical, Billings, MT, USA) at manufacturer’s recommended doses (KA-L, 1.5 g/d for 28-days); or, KA with equivalent loading (4 x 5 g/d for 7-days) and maintenance (5 g/d) doses of CrM (KA-H). Participants were asked to maintain their current training programs and record all workouts. Muscle biopsies from the vastus lateralis, fasting blood samples, body weight, DEXA determined body composition, and Wingate Anaerobic Capacity (WAC) tests were performed at 0, 7, and 28-days while 1RM strength tests were performed at 0 and 28-days. Data were analyzed by a repeated measures multivariate analysis of variance (MANOVA) and are presented as mean ± SD changes from baseline after 7 and 28-days, respectively. RESULTS: Muscle free creatine content obtained in a subgroup of 25 participants increased in all groups over time (1.4 ± 20.7 and 11.9 ± 24.0 mmol/kg DW, p = 0.03) after 7 and 28-days, respectively, with no significant differences among groups (KA-L −7.9 ± 22.3, 4.7 ± 27.0; KA-H 1.0 ± 12.8, 9.1 ± 23.2; CrM 11.3 ± 23.9, 22.3 ± 21.0 mmol/kg DW, p = 0.46). However, while no overall group differences were observed (p = 0.14), pairwise comparison between the KA-L and CrM groups revealed that changes in muscle creatine content tended to be greater in the CrM group (KA-L −1.1 ± 4.3, CrM 11.2 ± 4.3 mmol/kg DW, p = 0.053 [mean ± SEM]). Although some significant time effects were observed, no significant group x time interactions (p > 0.05) were observed in changes in body mass, fat free mass, fat mass, percent body fat, or total body water; bench press and leg press 1RM strength; WAC mean power, peak power, or total work; serum blood lipids, markers of catabolism and bone status, and serum electrolyte status; or, whole blood makers of lymphocytes and red cells. Serum creatinine levels increased in all groups (p < 0.001) with higher doses of creatine promoting greater increases in serum creatinine (p = 0.03) but the increases observed (0.1 – 0.2 mg/dl) were well within normal values for active individuals (i.e., <1.28 ± 0.2 mg/dl). Serum LDL was decreased to a greater degree following ingesting loading doses in the CrM group but returned to baseline during the maintenance phase. No side effects were reported. CONCLUSIONS: Neither manufacturers recommended doses of KA (1.5 g/d) or KA with equivalent loading (20 g/d for 7-days) and maintenance doses (5 g/d for 21-days) of CrM promoted greater changes in muscle creatine content, body composition, strength, or anaerobic capacity than CrM (20 g/d for 7-days, 5 g/d for 21-days). There was no evidence that supplementing the diet with a buffered form of creatine resulted in fewer side effects than CrM. These findings do not support claims that consuming a buffered form of creatine is a more efficacious and/or safer form of creatine to consume than creatine monohydrate. BioMed Central 2012-09-13 /pmc/articles/PMC3479057/ /pubmed/22971354 http://dx.doi.org/10.1186/1550-2783-9-43 Text en Copyright ©2012 Jagim et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Jagim, Andrew R
Oliver, Jonathan M
Sanchez, Adam
Galvan, Elfego
Fluckey, James
Riechman, Steven
Greenwood, Michael
Kelly, Katherine
Meininger, Cynthia
Rasmussen, Christopher
Kreider, Richard B
A buffered form of creatine does not promote greater changes in muscle creatine content, body composition, or training adaptations than creatine monohydrate
title A buffered form of creatine does not promote greater changes in muscle creatine content, body composition, or training adaptations than creatine monohydrate
title_full A buffered form of creatine does not promote greater changes in muscle creatine content, body composition, or training adaptations than creatine monohydrate
title_fullStr A buffered form of creatine does not promote greater changes in muscle creatine content, body composition, or training adaptations than creatine monohydrate
title_full_unstemmed A buffered form of creatine does not promote greater changes in muscle creatine content, body composition, or training adaptations than creatine monohydrate
title_short A buffered form of creatine does not promote greater changes in muscle creatine content, body composition, or training adaptations than creatine monohydrate
title_sort buffered form of creatine does not promote greater changes in muscle creatine content, body composition, or training adaptations than creatine monohydrate
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3479057/
https://www.ncbi.nlm.nih.gov/pubmed/22971354
http://dx.doi.org/10.1186/1550-2783-9-43
work_keys_str_mv AT jagimandrewr abufferedformofcreatinedoesnotpromotegreaterchangesinmusclecreatinecontentbodycompositionortrainingadaptationsthancreatinemonohydrate
AT oliverjonathanm abufferedformofcreatinedoesnotpromotegreaterchangesinmusclecreatinecontentbodycompositionortrainingadaptationsthancreatinemonohydrate
AT sanchezadam abufferedformofcreatinedoesnotpromotegreaterchangesinmusclecreatinecontentbodycompositionortrainingadaptationsthancreatinemonohydrate
AT galvanelfego abufferedformofcreatinedoesnotpromotegreaterchangesinmusclecreatinecontentbodycompositionortrainingadaptationsthancreatinemonohydrate
AT fluckeyjames abufferedformofcreatinedoesnotpromotegreaterchangesinmusclecreatinecontentbodycompositionortrainingadaptationsthancreatinemonohydrate
AT riechmansteven abufferedformofcreatinedoesnotpromotegreaterchangesinmusclecreatinecontentbodycompositionortrainingadaptationsthancreatinemonohydrate
AT greenwoodmichael abufferedformofcreatinedoesnotpromotegreaterchangesinmusclecreatinecontentbodycompositionortrainingadaptationsthancreatinemonohydrate
AT kellykatherine abufferedformofcreatinedoesnotpromotegreaterchangesinmusclecreatinecontentbodycompositionortrainingadaptationsthancreatinemonohydrate
AT meiningercynthia abufferedformofcreatinedoesnotpromotegreaterchangesinmusclecreatinecontentbodycompositionortrainingadaptationsthancreatinemonohydrate
AT rasmussenchristopher abufferedformofcreatinedoesnotpromotegreaterchangesinmusclecreatinecontentbodycompositionortrainingadaptationsthancreatinemonohydrate
AT kreiderrichardb abufferedformofcreatinedoesnotpromotegreaterchangesinmusclecreatinecontentbodycompositionortrainingadaptationsthancreatinemonohydrate
AT jagimandrewr bufferedformofcreatinedoesnotpromotegreaterchangesinmusclecreatinecontentbodycompositionortrainingadaptationsthancreatinemonohydrate
AT oliverjonathanm bufferedformofcreatinedoesnotpromotegreaterchangesinmusclecreatinecontentbodycompositionortrainingadaptationsthancreatinemonohydrate
AT sanchezadam bufferedformofcreatinedoesnotpromotegreaterchangesinmusclecreatinecontentbodycompositionortrainingadaptationsthancreatinemonohydrate
AT galvanelfego bufferedformofcreatinedoesnotpromotegreaterchangesinmusclecreatinecontentbodycompositionortrainingadaptationsthancreatinemonohydrate
AT fluckeyjames bufferedformofcreatinedoesnotpromotegreaterchangesinmusclecreatinecontentbodycompositionortrainingadaptationsthancreatinemonohydrate
AT riechmansteven bufferedformofcreatinedoesnotpromotegreaterchangesinmusclecreatinecontentbodycompositionortrainingadaptationsthancreatinemonohydrate
AT greenwoodmichael bufferedformofcreatinedoesnotpromotegreaterchangesinmusclecreatinecontentbodycompositionortrainingadaptationsthancreatinemonohydrate
AT kellykatherine bufferedformofcreatinedoesnotpromotegreaterchangesinmusclecreatinecontentbodycompositionortrainingadaptationsthancreatinemonohydrate
AT meiningercynthia bufferedformofcreatinedoesnotpromotegreaterchangesinmusclecreatinecontentbodycompositionortrainingadaptationsthancreatinemonohydrate
AT rasmussenchristopher bufferedformofcreatinedoesnotpromotegreaterchangesinmusclecreatinecontentbodycompositionortrainingadaptationsthancreatinemonohydrate
AT kreiderrichardb bufferedformofcreatinedoesnotpromotegreaterchangesinmusclecreatinecontentbodycompositionortrainingadaptationsthancreatinemonohydrate